adult attention deficit hyperactivity disorder

Centanafadine: New Hope for Adult ADHD?

by

Novel non-Stimulant Shows Promise for Adult ADHD: Centanafadine Demonstrates Clinically Meaningful Enhancement Table of Contents Novel non-Stimulant Shows Promise for Adult ADHD: Centanafadine Demonstrates Clinically Meaningful Enhancement Centanafadine Shows Promise in ADHD Treatment: A New Approach to Symptom Management Understanding Centanafadine’s Impact on ADHD Symptoms Expanding the Research: Pediatric Trials Yield Positive Results safety Profile … Read more

Centanafadine ‘Clinically Meaningful’ for Adult ADHD

by

LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and “clinically meaningful” for adult attention-deficit/hyperactivity disorder (ADHD), new research suggested. In a combined analysis of two phase 3 trials with a total of 859 adults, more patients who received the NDSRI had at least an … Read more

ADHD Rates, Adverse Outcomes Elevated in Adults With Autism

by

TOPLINE: Attention-deficit/hyperactivity disorder (ADHD) rates were 24%-37% higher in adults with autism than the general population and having both conditions was linked to worse outcomes, a new cohort study showed. METHODOLOGY: This population-based cohort study included more than 3.5 million Medicaid-enrolled adults aged 18 years or older (mean age, 33.5 years; 53% women; 60% White … Read more